All Updates

All Updates

icon
Filter
M&A
Motional receives USD 475 million from Hyundai; Hyundai to buy out stake from Aptiv for controlling 85% interest
Last-mile Delivery Automation
May 2, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Last-mile Delivery Automation

Last-mile Delivery Automation

May 2, 2024

Motional receives USD 475 million from Hyundai; Hyundai to buy out stake from Aptiv for controlling 85% interest

M&A

  • Hyundai is investing nearly USD 1 billion in a Hyundai-Aptiv autonomous vehicle joint venture, Motional, gaining a majority stake and providing the startup with capital for continued operations. The deal involves a direct investment of USD 475 million and purchasing additional equity for USD 448 million from its partner, Aptiv (11% stake), resulting in Hyundai controlling 85% of Motional.

  • Aptiv, which previously held a 50% stake in Motional, is reducing its investment. It cites the high costs and long timeframe associated with commercializing robotaxis.

  • The deal is expected to be completed by Q3 2024, subject to customary regulatory approvals and closing conditions.

  • Analyst QuickTake: Motional, resulting from a USD 4 billion collaboration between Hyundai and Aptiv, is working on commercializing autonomous taxis by 2024. However, the funding situation for Motional became uncertain as Aptiv decided to cut stake and discontinue future funding in January 2024, leaving Hyundai as the primary backer unless Motional attracted additional investors. We believe the new funds injected by Hyundai would help the company’s continued operations. Motional also secured a bridge loan to meet temporary financial needs in March 2024. The broader robotaxi industry is marked by uncertainty and gradual progress toward commercial viability, with incumbents like Alphabet’s Waymo expanding its services and others like GM’s Cruise recovering from setbacks.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.